Bayer is a life-sciences group in pharmaceuticals, crop science and consumer health, weighed by litigation and debt. It trades on Frankfurt Stock Exchange (XETRA) under the ticker BAYN, in the Pharma and Agriculture sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | BAYN |
| Exchange | Frankfurt Stock Exchange (XETRA) (BAYN) |
| Sector | Pharma & Agriculture |
| Headquarters | Leverkusen, Germany |
Bull Case & Risks
Bull Case
- Diversified pharma and ag-science
- New drug launches (Nubeqa, Kerendia)
- A deep-value, low valuation
Risks
- Glyphosate-litigation overhang
- High debt and pipeline gaps
Outlook
Bayer is a deep-value life-sciences turnaround, gated by glyphosate litigation and debt against a diversified base.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.